NCT03291262Unknown不适用
Survival Outcomes of Ovarian Malignancies in Chinese Population
Lei Li1 个研究点 分布在 1 个国家目标入组 5,000 人开始时间: 2017年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 5,000
- 试验地点
- 1
- 主要终点
- Overall survival
研究概览
简要总结
This study aims to determine survival outcomes (overall survival and progression-free survival) of primary ovarian malignancies in China and relevant risk factors in a prospective cohort study.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Primary ovarian malignancies.
排除标准
- •Metastatic malignancies to ovaries.
结局指标
主要结局
Overall survival
时间窗: 5 years
Periods from diagnosis of ovarian cancer to death
Progression-free survival
时间窗: 5 years
Periods from diagnosis of ovarian cancer or remission of disease to next recurrence
次要结局
未报告次要终点
研究者
Lei Li
Professor
Peking Union Medical College Hospital
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Survival Outcomes of Uterine Malignancies in Chinese PopulationEndometrial NeoplasmsSurvivalNCT03291275Lei Li10,000
进行中（未招募）
不适用
Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune RepertoireOvarian CancerNCT03614689Geneplus-Beijing Co. Ltd.104
Unknown
不适用
Survival Outcomes of Uterine Cervical Malignancies in Chinese PopulationUterine Cervical NeoplasmsSurvivalNCT03291236Lei Li5,000
招募中
不适用
The Registry of Genetic Alterations of Taiwan Ovarian CancerOvarian CancerNCT06127446National Health Research Institutes, Taiwan300
终止
不适用
Long Term Survivors in Ovarian CancerOvarian CancerNCT03128294University Medical Center Groningen69